Yourgene Health Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
May 22,2023: Yourgene genomic services to support MHC's Boots agreement
May 22,2023: Yourgene Health announces Directorate change.
Apr 27,2023: Yourgene Health : Full year unaudited trading update
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Yourgene Health Ltd (Yourgene Health), a subsidiary of Novacyt UK Holdings Ltd is a molecular diagnostics company that develops and commercializes genetic products and services. Its major products include non-invasive prenatal tests for Down's syndrome and other genetic disorders, invasive rapid aneuploidy tests, cystic fibrosis screening tests, male infertility tests and genetic disease tests. Yourgene Health develops non-invasive screening tests using proprietary DNA analysis technology. The company provides NIPT tests and services to clinical laboratories and healthcare professionals. Yourgene Health markets products directly and through a network of distributors across the world. The company has a presence in the UK, Singapore, Taipei, the US and Canada, among others. Yourgene Health is headquartered in Manchester, the UK.Yourgene Health Plc Key Recent Developments
Jul 26,2023: Yourgene Health : Yourgene Health Plc Logofive-Year Contract Extension With IlluminaMay 22,2023: Yourgene genomic services to support MHC's Boots agreement
May 22,2023: Yourgene Health announces Directorate change.
Apr 27,2023: Yourgene Health : Full year unaudited trading update
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Company’s Recent Developments
Section 5 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GeneDX LLC
- Roche Diagnostics International Ltd
- OptiGene Ltd
- ERBA Molecular Ltd
- ANGLE Plc